Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (471)	7/15/2002 12:34:12 PM
From: Jibacoa	Read Replies (1) \| Respond to of 544

DRTE It is not really a Biotech or Pharma Co., but a software Co.<g> However, its major customers are large, multinational Pharma Cos., including: ABT, AGN, AZN, AVE, BMY, CLL, DNPCY.PK, LLY, FRX, NVS, PFE,TDCHF.PK,TINLY.PK, WYE and a few others.<g> More than half of its 2001 revenues reportedly came from its two largest clients, PFE and BMY. The company had an "upgrade" on June 3 from Grunthal to Near Term "Outperform" from Near Term "Perform".<g> It is likely that the earning report to be announced on July 25 will be better than last year's since in the June Q of 2001 the Co. had a "non-recurring" charge of $15.75M <g> (All the other Qs including the last one have been on the black) At any rate, what it seems interesting is that the company afte the last five days of steady decline may have found support at the 7.50 level since it is up today in spite of the general market.<g> siliconinvestor.com Bernard

To: Jibacoa who wrote (471)	7/19/2002 3:43:02 PM
From: Jibacoa	Read Replies (1) \| Respond to of 544

The NAZand the DOW As I mentioned on Monday, the DOW seems that will test the September 2001 L at 8062 (Today's L so far at 7970 is already well past that point in spite of the "curbs in".<g>) The NAZ's September L and its nearest support is at 1320 which was tested on July 11.(It is already below it at 1311.<g>) In general not a good day for the market. Let's hope there is a "selling climax" on Monday, but overall the picture doesn't look good. Among the few Biotechs staying out of the red today: AMGN ARDN AVN CALP CPHD CRGN CYGN DCGN KOSN IMNR INGN GENR EBIO DPII NTII PGNX POZN QTRN RIGL SGMO STEM VGNX Bernard